Dr. Braley is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1500 E. Medical Center Dr.
1st Floor Taubman Ctr Recp C
Ann Arbor, MI 48109Phone+1 734-936-9010
Education & Training
University of Michigan School of Public HealthM.S., Clinical Research Design and Statistical Analysis, 2009 - 2011
University of Michigan Health SystemFellowship, Neuroimmunology & Multiple Sclerosis, 2008 - 2011- University of MichiganResidency, Neurology, 2005 - 2008
Trinity Health Ann Arbor HospitalInternship, Internal Medicine, 2004 - 2005
Wayne State University School of MedicineClass of 2004
Certifications & Licensure
MI State Medical License 2008 - 2027- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- Holtom-Garrett Family Professor of Neurology University of Michigan
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Dimethyl Fumarate for Obstructive Sleep Apnea Start of enrollment: 2015 May 01
- CPAP to Treat Cognitive Dysfunction in MS Start of enrollment: 2015 Nov 12
- Cognitive Behavioral Therapy, Modafinil, or Both for Multiple Sclerosis Fatigue Start of enrollment: 2018 Nov 15
- Join now to see all
Publications & Presentations
PubMed
- Resilience, Mental Health, Sleep, and Smoking Mediate Pathways Between Lifetime Stressors and Multiple Sclerosis Severity.Carri S Polick, Hala Darwish, Leonardo Pestillo de Oliveira, Ali Watson, Joao Ricardo Nickenig Vissoci
Sclerosis. 2024-12-01 - Sleep disturbances and progression of mobility disability: Longitudinal findings from the Nurses' Health Study.Daniel Whibley, Monica M Shieu, Galit Levi Dunietz, Tiffany J Braley
Sleep Epidemiology. 2024-12-01 - 2 citationsComparative effectiveness of cognitive behavioural therapy, modafinil, and their combination for treating fatigue in multiple sclerosis (COMBO-MS): a randomised, stati...Tiffany J Braley, Dawn M Ehde, Kevin N Alschuler, Roderick Little, Yee To Ng
The Lancet. Neurology. 2024-11-01
Press Mentions
Millions of Americans Likely Have Sleep Apnea—Could It Raise the Risk of Dementia?November 14th, 2024- Obstructive Sleep Apnea Increases Risk for Dementia in Midlife Adults, Especially WomenNovember 11th, 2024
- Sleep Apnea Increases Risk for Dementia in Older Adults over TimeNovember 6th, 2024
- Join now to see all
Grant Support
- Mechanisms of cannabidiol in persons with MS: The role of sleep and pain phenotypeNIH/NCCIH2021–2026
- Pathways between OSA and cognitive decline in older women and men: a longitudinal population-based studyNIH/NIA2021–2025
- A randomized controlled trial of telephone-delivered COgnitive behavioral-therapy, Modafinil, and combination therapy of BOth interventions for fatigue in MS (“COMBO-MS”)Patient-Centered Outcomes Research Institute2018–2022
- A randomized trial of positive airway pressure therapy to treat cognitive dysfunction in MS patients with obstructive sleep apneaNational Multiple Sclerosis Society2015–2020
- Recognition and treatment of obstructive sleep apnea among Medicare beneficiariesAmerican Sleep Medicine Foundation2015–2019
- Dimethyl fumarate: a novel therapeutic agent for obstructive sleep apneaUniversity of Michigan Medical School’s Michigan Translation and Commercialization (MTRAC) for Life Sciences Program2015–2016
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
